Clariant, CD&R discuss Ashland acquisition in potential $3.39 billion chemicals deal
Ashland is exploring strategic options months after activist investors pushed the U.S. chemicals maker to pursue a sale. Talks now involve Swiss specialty chemicals group Clariant and private ...